ANTHOSTHERAPEUTICS.COM: Keyword Density Checker

Total words: 15010 | 2-word phrases: 3760 | 3-word phrases: 4772 | 4-word phrases: 5094

PAGE INFO

Title	Try to keep the title under 60 characters (8 characters) Anthos \|
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (19 characters) ANTHOS THERAPEUTICS

#	Keyword	Frequency	Density
1	back	20	0.42%
2	the board of	14	0.29%
3	member of the	12	0.25%
4	the university of	11	0.23%
5	board of directors	10	0.21%
6	from the university	10	0.21%
7	a member of	9	0.19%
8	of the board	8	0.17%
9	at anthos therapeutics	8	0.17%
10	he was a	7	0.15%
11	a bachelor of	6	0.13%
12	of directors of	6	0.13%
13	prior to joining	6	0.13%
14	on the board	5	0.10%
15	a phd in	5	0.10%
16	5 years of	5	0.10%
17	blackstone life sciences	5	0.10%
18	of anthos therapeutics	5	0.10%
19	experience in the	5	0.10%
20	the pharmaceutical industry	4	0.08%
21	an observer to	4	0.08%
22	as part of	4	0.08%
23	observer to the	4	0.08%
24	to the board	4	0.08%
25	prior to that	4	0.08%
26	and head of	4	0.08%
27	is an observer	4	0.08%
28	he was the	4	0.08%
29	the head of	4	0.08%
30	years of experience	4	0.08%

#	Keyword	Frequency	Density
1	from the university of	10	0.20%
2	the board of directors	9	0.18%
3	a member of the	8	0.16%
4	member of the board	7	0.14%
5	of the board of	7	0.14%
6	board of directors of	6	0.12%
7	an observer to the	4	0.08%
8	is an observer to	4	0.08%
9	observer to the board	4	0.08%
10	to the board of	4	0.08%
11	as part of its	3	0.06%
12	the blackstone life sciences	3	0.06%
13	blackstone as part of	3	0.06%
14	in the life sciences	3	0.06%
15	is the head of	3	0.06%
16	acquisition of clarus in	3	0.06%
17	board of directors at	3	0.06%
18	at anthos therapeutics dr	3	0.06%
19	of clarus in december	3	0.06%
20	clarus in december 2018	3	0.06%
21	years of experience in	3	0.06%
22	news provided by anthos	3	0.06%
23	on the board of	3	0.06%
24	holds a bachelor of	3	0.06%
25	metabolic disease read more	2	0.04%
26	group leader at abbvie	2	0.04%
27	in early and late	2	0.04%
28	cardiovascular and metabolic disease	2	0.04%
29	30 years of industry	2	0.04%
30	phd from the university	2	0.04%
31	product lifecycle and cocreating	2	0.04%
32	lifecycle and cocreating a	2	0.04%
33	over 25 years of	2	0.04%
34	patients have transitioned to	2	0.04%
35	purification group leader at	2	0.04%
36	on the boards of	2	0.04%
37	announces 84 of  eligible	2	0.04%
38	a key role in	2	0.04%
39	have transitioned to abelacimab	2	0.04%
40	is a member of	2	0.04%

#	URL	Whois	Check
1	https://webreprints.djreprints.com/2479771.html	Whois	djreprints.com
2	https://www.cnbc.com/video/2021/05/11/big-bets-on-biotech-healthy-returns-summit-with-nicholas-galakatos.html	Whois	cnbc.com